Get App
Download App Scanner
Scan to Download
Advertisement

Sammaan Capital Gets SEBI Nod To IHC Deal, Clearing Door For Rs 8,850-Crore Acquisition

"Now with the receipt of the SEBI approvals, all regulatory approvals for consummation of the proposed transaction are in place," Sammaan Capital said.

Sammaan Capital Gets SEBI Nod To IHC Deal, Clearing Door For Rs 8,850-Crore Acquisition
Photo Source: NDTV Profit
  • SEBI approved Avenir Investment's controlling stake acquisition in Sammaan Capital Ltd
  • Avenir will invest Rs 8,850 crore via preferential issue to gain 41.23% stake
  • Over 33 crore shares will be issued at Rs 139 each to raise Rs 4,587 crore in first tranche
Did our AI summary help?
Let us know.

The Securities and Exchange Board of India approved the acquisition of controlling stake in Sammaan Capital Ltd. by Avenir Investment RSC Ltd., an affiliate of Abu Dhabi-based International Holding Company. The company already got nod from shareholders, lenders and creditors, stock exchanges, the Competition Commission of India, and the Reserve Bank of India.

"Now with the receipt of the SEBI approvals, all regulatory approvals for consummation of the proposed transaction are in place... The company and the investor are now engaged to conclude the proposed transaction at the earliest," Sammaan Capital said in an exchange filing late Friday.

As part of the deal signed in October last year, Avenir will invest Rs 8,850 crore by way of preferential issue in the non-banking financial company to gain a shareholding of nearly 41.23%. Over 33 crore shares will be issued to the investor at Rs 139 apiece in order to raise Rs 4,587 crore, while the rest will be through two tranches of warrants.

Avenir will then launch an open offer which could raise its stake to 63.36% in Sammaan Capital, formerly known as Indiabulls Housing Finance.

Sammaan Capital shares ended 1% higher at Rs 148.35 on the NSE, ahead of the announcement, compared to a 2.1% advance in the benchmark Nifty 50 on Friday. The stock is up 36% in the last 12 months and 3.4% on a year-to-date basis.

ALSO READ: SEBI Approves IPO Plans Of Symbiotec Pharmalab, Vishvaraj Environment, SAEL; Jindal Supreme Withdraws

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source